pharmacovigilanz

Pharmacovigilanz is the science and activities relating to the detection, assessment, understanding, and prevention of adverse effects or any other medicine-related problem. It is a crucial component of drug safety and public health, aiming to ensure that medicines are used as safely and effectively as possible throughout their lifecycle. The primary goal of pharmacovigilanz is to identify potential risks associated with medicines once they are available to a wider population, beyond the controlled conditions of clinical trials.

This process involves collecting reports of suspected adverse drug reactions from various sources, including healthcare professionals, patients, and pharmaceutical companies. These reports are then analyzed to identify patterns and potential causal relationships between a medicine and an adverse event. Regulatory authorities use this information to update product information, issue warnings, or even withdraw medicines from the market if significant safety concerns arise.

Pharmacovigilanz activities are conducted globally by national regulatory agencies, international organizations like the World Health Organization, and the pharmaceutical industry. It is a continuous process that begins during drug development and continues long after a medicine has been approved and marketed. The ultimate aim is to protect public health by minimizing the risks associated with medication use and maximizing its benefits.